Company / Current Assets
Alaunos Therapeutics, Inc. Current Assets History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.0M
FY2025
5-year range
$2.0M / $78.8M
FY2021-FY2025
Trend
-27.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 5 consecutive years, from $131M in FY2020 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -56.7%.
Declined from $8M to $2M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -66.7%
- 5-Year CAGR
- -56.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Alaunos Therapeutics, Inc.'s current assets has declined for 5 consecutive years.
- 5-year CAGR of -56.7%, indicating a declining trend.
- In FY2025, current assets decreased 27.8% year-over-year.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0M | -27.8% |
| FY2024 | $2.8M | -66.7% |
| FY2023 | $8.3M | -84.6% |
| FY2022 | $53.8M | -31.8% |
| FY2021 | $78.8M | -39.6% |
| FY2020 | $130.6M | +23.8% |
| FY2019 | $105.5M | +25.2% |
| FY2018 | $84.3M | +19.9% |
| FY2013 | $70.3M | -12.4% |
| FY2012 | $80.3M | -24.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026